Astellas Pharma Inc.

4503.T

TSEBiotechnology🇺🇸North America

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

None scheduled

Drug Pipeline

Drug Name	Phase	Indication	Designations
mycophenolate mofetil	Phase 3	KIDNEY TRANSPLANTATION	-
Basiliximab	Phase 3	Liver Transplantation	-
ASP1585	Phase 3	Chronic Kidney Disease	-
Tacrolimus Cream	Phase 3	Psoriasis	-
YM529 / ONO-5920	Phase 3	Osteoporosis	-
Sevelamer hydrochloride	Phase 3	Chronic Kidney Disease	-
ASP1941	Phase 3	Type 2 Diabetes Mellitus	-
Placebo	Phase 3	Acute Myeloid Leukemia	-
FK949E	Phase 3	Bipolar Disorder	-
Zolpidem MR	Phase 3	Sleep Initiation and Maintenance Disorders	-
Methotrexate	Phase 3	Rheumatoid Arthritis	-
RSD1235	Phase 3	Atrial Fibrillation	-
Regadenoson	Phase 3	Coronary Artery Disease (CAD)	-
ipragliflozin	Phase 3	Type 2 Diabetes Mellitus	-
alpha glucosidase inhibitor	Phase 3	Type 2 Diabetes Mellitus	-
leuprorelin acetate	Phase 3	Prostate Cancer	-
Prograf	Phase 3	Kidney Transplantation	-
Ramosetron	Phase 3	Vomiting	-
FK506MR	Phase 3	Kidney Transplantation	-
YM178	Phase 3	Urinary Bladder, Overactive	-
Exisulind	Phase 3	Non-Small Cell Lung Cancer	-
tacrolimus ointment	Phase 3	Dermatitis, Atopic	-
Pioglitazone	Phase 3	Type 2 Diabetes Mellitus	-
Tacrolimus modified-release	Phase 3	Liver Transplantation	-
zolbetuximab	Phase 3	Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer	-
solifenacin succinate	Phase 3	Urinary Bladder, Overactive	-
Simulect	Phase 3	Kidney Transplantation	-
Micafungin	Phase 3	Candidiasis	-
Prograf-XL	Phase 3	Liver Transplantation	-
fluconazole	Phase 3	Liver Transplantation	-
alefacept	Phase 3	Chronic Plaque Psoriasis	-
Enzalutamide	Phase 3	Metastatic Hormone Sensitive Prostate Cancer	-
tolterodine	Phase 3	Urinary Bladder, Overactive	-
pudexacianinium chloride	Phase 3	Intraoperative Ureter Visualization	-
Roxadustat	Phase 3	Chronic Kidney Disease	-
methylprednisolone and prednisone	Phase 3	Kidney Transplantation	-
ASP5094	Phase 2	Rheumatoid Arthritis (RA)	-
tacrolimus	Phase 2	Liver Transplantation	-
Gilteritinib	Phase 2	Acute Myeloid Leukemia (AML)	-
ASP5541	Phase 2	Prostate Cancer	-
Advagraf	Phase 2	Heart Transplantation	-
ASP7517	Phase 2	Advanced Malignancies	-
FK778	Phase 2	Liver Transplantation	-
peficitinib	Phase 2	Arthritis, Rheumatoid	-
YM060	Phase 2	Irritable Bowel Syndrome	-
ASP2151	Phase 2	Herpes Zoster	-
Fezolinetant	Phase 2	Menopause	-
ASP8062	Phase 2	Fibromyalgia	-
linsitinib	Phase 2	Advanced Solid Tumors	-
Tacrolimus Ointment 0.03%	Phase 2	Dermatitis, Atopic	-
YM150	Phase 2	Thromboembolism	-
ASP9831	Phase 2	Non-Alcoholic Steatohepatitis	-
Isavuconazonium sulfate	Phase 2	Invasive Mucormycosis	-
FK788	Phase 2	Hepatitis C	-
OSI-461	Phase 2	Chronic Lymphocytic Leukemia	-
AGS-1C4D4	Phase 2	Carcinoma, Pancreatic Ductal	-
ASP1517	Phase 2	Anemia in Chronic Kidney Disease Patients Not on Dialysis	-
abiraterone acetate	Phase 2	Prostate Cancer	-
Metformin	Phase 2	Type 2 Diabetes Mellitus	-
OSI-906	Phase 2	Non-Small Cell Lung Cancer (NSCLC) With Nonprogression Following 4 Cycles of Platinum-based Chemotherapy	-
ASP7991	Phase 2	Secondary Hyperparathyroidism	-
Tacrolimus Modified Release (MR)	Phase 2	Kidney Transplantation	-
darbepoetin alfa	Phase 2	Renal Anemia Associated With Chronic Renal Failure (CRF)	-
Steroids	Phase 2	De Novo Kidney Transplantation	-

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

Regulatory Approvals

4503.T News